Disease: Epidermal nevus vitamin D resistant rickets
- A case report to assess the safety and efficacy of Burosumab, an investigational antibody to FGF23, in a single pediatric patient with Epidermal Nevus Syndrome and associated hypophosphatemic rickets
- A Case Report: First Long-Term Treatment With Burosumab in a Patient With Cutaneous-Skeletal Hypophosphatemia Syndrome
- Burosumab: First Global Approval
- Cutaneous skeletal hypophosphatemia syndrome (CSHS) is a multilineage somatic mosaic RASopathy
- Cutaneous skeletal hypophosphatemia syndrome: clinical spectrum, natural history, and treatment
- Epidermal Nevus Syndrome with Hypophosphatemic Rickets
- Epidermal nevus syndrome with hypophosphatemic rickets in a young girl
- Epidermal nevus syndromes
- Hypophosphatemic rickets associated with giant hairy nevus
- Keratinocytic epidermal nevi associated with localized fibro-osseous lesions without hypophosphatemia
- Mosaic NRAS Q61R mutation in a child with giant congenital melanocytic naevus, epidermal naevus syndrome and hypophosphataemic rickets
- New Therapies for Hypophosphatemia-Related to FGF23 Excess
- Rickets in association with skin diseases and conditions: A review with emphasis on screening and prevention
- Successful treatment with MEK-inhibitor in a patient with NRAS-related cutaneous skeletal hypophosphatemia syndrome
- The efficacy and safety of burosumab in two patients with cutaneous skeletal hypophosphatemia syndrome